Pharmacovgillance

Adverse event reporting vs. scientific publication

Acta Marisiensis - Seria Medica publishes scientific research and meeting abstracts. Authors, researchers, and trial sponsors remain responsible for reporting individual safety reports and adverse events directly to regulatory authorities (such as the ANMDMR or EMA) within legally mandated timeframes.

Inquiries regarding published articles

• For published full-text articles, pharmaceutical companies or pharmacovigilance representatives requesting additional details on reported side effects should contact the corresponding author directly using the email address provided on the article page.

• The journal editorial office does not store patient-level clinical data or additional pharmacovigilance details beyond what is published in the final manuscript.

Inquiries regarding congress / meeting abstracts

• Abstract publications contain condensed scientific summaries.

• The journal office does not hold supplementary data for conference abstracts.

• Pharmaceutical companies and regulatory agencies seeking further information regarding data presented in meeting abstracts must contact the event organizers or the abstract authors directly.